Company Intelligence
Icardio.AI
Icardio.AI provides enterprise-grade artificial intelligence solutions, delivering specialized Icardio.AI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Los Angeles, United States
- Website
- icardio.ai
- Founded
- 2023
- Stage
- Techstars Healthcare sponsored by Cedars-Sinai, Point32Health, UCI Health, and UnitedHealthcare
- Status
- Active
- Products
- 1
- Reports
- 4
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Icardio.AI is an Enterprise Software AI company based in Los Angeles, United States, founded in 2023.
Icardio.AI offers interpreting echocardiograms using machine learning algorithms.
What it builds
Icardio.AI Platform
Why It Matters
Icardio.AI provides enterprise-grade artificial intelligence solutions, delivering specialized Icardio.AI Platform technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Icardio.AI
Explore Icardio.AI by Icardio.AI. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical architecture, and…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Icardio.AI
Industry
Products
Capabilities
Icardio.AI offers interpreting echocardiograms using machine learning algorithms.
Features
Icardio.AI offers interpreting echocardiograms using machine learning algorithms.
Country
Related companies
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Icardio.AI do?
Icardio.AI specializes in artificial intelligence, developing Icardio.AI Platform to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Icardio.AI based and when was it founded?
Icardio.AI is based in United States and was founded in 2023.
What are the main products offered by Icardio.AI?
The flagship platform from Icardio.AI is Icardio.AI Platform, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Icardio.AI?
Icardio.AI primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.